 |
|
The role of different viral biomarkers on the management of chronic hepatitis B
Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, Wai Kay Seto, Man-Fung Yuen
Clin Mol Hepatol. 2023;29(2):263-276. Published online 2023 Jan 19 DOI: https://doi.org/10.3350/cmh.2022.0448
|
|
Citations to this article as recorded by
 Hepatitis B Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies
Ivana Lazarevic, Ana Banko, Danijela Miljanovic, Maja Cupic
Pathogens.2024; 13(1): 46. CrossRef ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B
Ryan Hin-Man Leung, Rex Wan-Hin Hui, Lung-Yi Mak, Xianhua Mao, Kevin Sze-Hang Liu, Danny Ka-Ho Wong, James Fung, Wai-Kay Seto, Man-Fung Yuen
Journal of Hepatology.2024; 81(2): 218. CrossRef Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosis
Hyunjae Shin, Won-Mook Choi, Seung Up Kim, Yunmi Ko, Youngsu Park, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Fabien Zoulim
JHEP Reports.2024; 6(7): 101089. CrossRef Linvencovir: Paving the way for functional cure in hepatitis B
Jiwon Yang, Jonggi Choi
Clinical and Molecular Hepatology.2024; 30(2): 164. CrossRef Editorial: High qHBsAg—is it a good or bad signal?
Beom Kyung Kim
Alimentary Pharmacology & Therapeutics.2024; 59(12): 1616. CrossRef Role of hepatitis B core‐related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta‐analysis
Qi‐Hang Cao, Hui Liu, Lun‐Jie Yan, Han‐Chao Wang, Zi‐Niu Ding, Xin‐Cheng Mao, Rui‐Zhe Li, Guo‐Qiang Pan, Xiao Zhang, Bao‐Wen Tian, Cheng‐Long Han, Zhao‐Ru Dong, Si‐Yu Tan, Dong‐Xu Wang, Yu‐Chuan Yan, Tao Li
Journal of Gastroenterology and Hepatology.2024;[Epub] CrossRef Current perspectives of viral hepatitis
Daisuke Usuda, Yuki Kaneoka, Rikuo Ono, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge, Riki Sakurai, Kenji Kawai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou,
World Journal of Gastroenterology.2024; 30(18): 2402. CrossRef CD4+ T cell counts and soluble programmed death-1 at baseline correlated with hepatitis B surface antigen decline in HIV/HBV coinfection during combined antiretroviral therapy
Xiaodi Li, Ling Xu, Lianfeng Lu, Xiaosheng Liu, Yang Yang, Yuanni Wu, Yang Han, Xiaoxia Li, Yanling Li, Xiaojing Song, Wei Cao, Taisheng Li
Frontiers in Cellular and Infection Microbiology.2023;[Epub] CrossRef Opportunities and challenges for hepatitis B cure
Armando Andres Roca Suarez, Fabien Zoulim
eGastroenterology.2023; 1(2): e100021. CrossRef Non-Invasive Prediction Scores for Hepatitis B Virus- and Hepatitis D Virus-Infected Patients—A Cohort from the North-Eastern Part of Romania
Laura Iulia Grecu, Camelia Sultana, Mariana Pavel-Tanasa, Simona Maria Ruta, Mihaela Chivu-Economescu, Lilia Matei, Ramona Gabriela Ursu, Elena Iftimi, Luminita Smaranda Iancu
Microorganisms.2023; 11(12): 2895. CrossRef
|